Amphastar Pharmaceuticals, Inc. (AMPH)

23.18 -0.66 (-2.77%) USD  |  NASDAQ  |  Sep 04, 16:00
22.90 -0.28 (-1.21%) After-Hours: 20:00
More

Amphastar Pharmaceuticals SG&A Expense (TTM) : 139.25M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for AMPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 139.25M
March 31, 2026 131.90M
December 31, 2025 129.81M
September 30, 2025 126.42M
June 30, 2025 99.27M
March 31, 2025 97.34M
December 31, 2024 94.52M
September 30, 2024 92.90M
June 30, 2024 88.15M
March 31, 2024 84.85M
December 31, 2023 80.39M
September 30, 2023 74.75M
June 30, 2023 72.46M
March 31, 2023 69.20M
December 31, 2022 66.59M
September 30, 2022 65.19M
June 30, 2022 64.08M
March 31, 2022 67.03M
December 31, 2021 68.92M
September 30, 2021 70.04M
June 30, 2021 69.74M
March 31, 2021 70.99M
December 31, 2020 65.16M
September 30, 2020 63.32M
June 30, 2020 62.21M
Date Value
March 31, 2020 57.68M
December 31, 2019 63.11M
September 30, 2019 65.54M
June 30, 2019 66.67M
March 31, 2019 64.79M
December 31, 2018 58.04M
September 30, 2018 52.48M
June 30, 2018 50.54M
March 31, 2018 50.82M
December 31, 2017 50.92M
September 30, 2017 52.26M
June 30, 2017 50.93M
March 31, 2017 47.89M
December 31, 2016 47.30M
September 30, 2016 45.12M
June 30, 2016 43.24M
March 31, 2016 45.22M
December 31, 2015 46.97M
September 30, 2015 48.22M
June 30, 2015 49.03M
March 31, 2015 46.24M
December 31, 2014 39.74M
September 30, 2014 37.76M
June 30, 2014 37.76M
March 31, 2014 35.49M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Viatris, Inc. 3.981B
Supernus Pharmaceuticals, Inc. 560.88M
Liquidia Corp. 192.66M
ANI Pharmaceuticals, Inc. 324.76M
Corcept Therapeutics, Inc. 556.47M